[{"id":"0886218f-ab90-4385-981e-a217b909ee46","acronym":"","url":"https://clinicaltrials.gov/study/NCT00644072","created_at":"2021-01-18T02:23:47.949Z","updated_at":"2024-07-02T16:37:20.476Z","phase":"Phase 1","brief_title":"SNX-5422 to Treat Solid Tumor Cancers and Lymphomas","source_id_and_acronym":"NCT00644072","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" HSP90AA1","pipe":"","alterations":" ","tags":["HSP90AA1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SNX-5422"],"overall_status":"Completed","enrollment":" Enrollment 33","initiation":"Initiation: 03/07/2008","start_date":" 03/07/2008","primary_txt":" Primary completion: 06/30/2009","primary_completion_date":" 06/30/2009","study_txt":" Completion: 06/16/2011","study_completion_date":" 06/16/2011","last_update_posted":"2017-07-02"}]